Document Page: First | Prev | Next | All | Image | This Release | Search
File: 970107_sep96_decls14_0003.txt
Subject: MEDICAL PROD UNDER FDA REG REQUIRED CONSIDER FOR DEPLOYMENT
Unit: OTSG
Parent Organization: HSC
Box ID: BX003201
Folder Title: MEDICAL PRODUCTS UNDER FDA REGULATIONS
Document Number: 930001
Folder Seq #: 930000
3. Ribavirin 200 mg Capsules. 1
a. IND # 16,666, sponsored by the US Army Office of the
Surgeon General.
b. Manufacturer: Viratech
c. IND listed indication: Hemorrhagic Fever with Renal
Syndrome, Lassa Fever, and Argentine Hemorrhagic Fever. The
indication intended for use in operation Desert Shield is for the
postexposure prophylaxis of Crimean Congo Hemorrhagic Fever, Rift
Valley Fever, and Hemorrhagic Fever with Renal Syndrome.
d. Operation Desert Shield status: required immediately.
e. Consequences of not using this product in operation
Desert Shield: Medical and other support personnel exposed to
patients with Congo Crimean Hemorrhagic Fever risk contraction of
the disease.
f. Informed consent status: Informed consent will be
requested of recipients.
g. Projected Availability for Operation Desert Shield: 7
October 1990.
f. Point of Contact: Dr. Liu, 301-663-2051
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 11 f:/Week-36/BX003201/MEDICAL PRODUCTS UNDER FDA REGULATIONS/medical prod under fda reg required consider for:01029715471415
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003201
Unit = OTSG
Parent Organization = HSC
Folder Title = MEDICAL PRODUCTS UNDER FDA REGULATIONS
Folder Seq # = 930000
Subject = MEDICAL PROD UNDER FDA REG REQUIRED CONSIDER FOR
Document Seq # = 930001
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 02-JAN-1997